Mark A. Glickman
Board Member
MetaVia Inc. (MTVA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark A. Glickman
Mark A. Glickman is recorded as Board Member at MetaVia Inc. (MTVA). MetaVia Inc. reported in an 8-K filed May 12, 2023 that Mark A. Glickman was appointed Class III director, effective May 11, 2023.
“On May 11, 2023, the Board of Directors (the "Board") of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the "Company"), on the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), appointed Mark A. Glickman, effective immediately, to serve as a Class III director to hold office for a term expiring at the Company's 2025 annual meeting of the Company's stockholders, which is the next stockholder meeting at which Class III directors will be elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MetaVia Inc.
Other people whose current roles at this company are on record from its filings.
- Ben Gil Price CEO
- Hyung Heon Kim CEO, CFO, Chief Accounting Officer, Board Member
- Joseph Hooker CEO, CFO, Chief Accounting Officer
- Richard Kang CEO
- Douglas J. Swirsky Chairman, Board Member
- Marshall H. Woodworth CFO, Chief Accounting Officer
- Marshall Woodworth CFO
- Akash Bakshi COO
- Andrew Koven Board Member
- D. Gordon Strickland Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.